Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-079738
Filing Date
2025-05-30
Accepted
2025-05-30 16:15:24
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pstv-20250331.htm   iXBRL 10-Q 1920083
2 EX-31.1 pstv-ex31_1.htm EX-31.1 15418
3 EX-31.2 pstv-ex31_2.htm EX-31.2 12303
4 EX-32.1 pstv-ex32_1.htm EX-32.1 17619
  Complete submission text file 0000950170-25-079738.txt   7515663

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20250331.xsd EX-101.SCH 1149664
68 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20250331_htm.xml XML 1112516
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 251011110
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)